Evaluation of Glycemic Control, Lifestyle and Clinical Characteristics in Patients with Type 2 Diabetes Treated at King Abdullah University Hospital in Jordan



      The study aimed to assess glycemic control in a Jordanian population with type 2 diabetes and to explore the sociodemographic, clinical and medication-related factors as well as the anthropometric indexes and laboratory values associated with and possibly contributing to unsatisfactory glycemic control.


      We included 237 patients previously diagnosed as having type 2 diabetes. Data were collected through direct interviews. Sociodemographic and clinical details were collected using a questionnaire designed for the purpose of the study, anthropometric measurements were obtained at the time of the interviews, and laboratory data were extracted from the medical records of King Abdullah University Hospital.


      Of the participants, 60.8% were found to have unsatisfactory glycemic control (glycated hemoglobin levels ≥7%). Unsatisfactory glycemic control was associated with younger ages at diabetes diagnosis, higher mean weights and higher prevalences of diabetic neuropathy. No relationships were found among glycemic control and body mass index, waist circumference or central obesity. Patients with adequate control were more likely to have health insurance and to have hypothyroidism as a comorbidity. Insulin use and medication plans containing insulin were associated with unsatisfactory control. Patients with unsatisfactory control had higher mean levels of low-density lipoproteins and triglycerides and lower mean levels of high-density lipoproteins. Moreover, elevated triglycerides (≥150 mg/dL) and dyslipidemia were associated with unsatisfactory glycemic control.


      More than half of the participants had unsatisfactory glycemic control, highlighting the need for a change in the approach and strategies used for patients with diabetes in Jordan. Factors associated with glycemic control that were found in this study should be further studied and used in the prevention and management of diabetes.



      L'étude visait à évaluer le contrôle glycémique d'une population jordanienne atteinte de diabète de type 2, et d'explorer les facteurs sociodémographiques, cliniques et ceux liés à la médication ainsi que les indices anthropométriques et les données biologiques associées contribuant éventuellement à un contrôle glycémique insatisfaisant.


      Nous avons inclus 237 patients préalablement diagnostiqués comme étant atteints de diabète de type 2. Les données ont été recueillies lors d'entretiens directs. Les renseignements d'ordre sociodémographiques et cliniques ont été collectés à l'aide d'un questionnaire conçu dans le cadre de l'étude, les mesures anthropométriques ont été obtenues au moment des entretiens, et les données biologiques ont été extraites des dossiers médicaux de l'hôpital universitaire du roi Abdallah.


      Parmi les participants, 60,8% ont été identifiés comme ayant un contrôle glycémique insatisfaisant (taux d'hémoglobine glyquée≥7%). Un contrôle glycémique insatisfaisant a été associé à un âge plus jeune lors du diagnostic du diabète, un poids moyen plus élevé, et une prévalence plus élevée de neuropathie diabétique. Aucune relation n'a été trouvée entre contrôle glycémique et indice de masse corporelle, tour de taille, ou obésité abdominale. Les patients avec un contrôle adéquat étaient plus susceptibles d'avoir une assurance santé et d'avoir une hypothyroïdie comme comorbidité. L'utilisation de l'insuline et les planifications d'une médication contenant de l'insuline ont été associées à un contrôle insatisfaisant. Les patients ayant un contrôle insatisfaisant avaient des niveaux moyens plus élevées de lipoprotéines de basse densité et de triglycérides, et un niveau moyen plus bas de lipoprotéines de haute densité. De plus, des triglycérides élevés (≥150 mg/dL) et une dyslipidémie ont été associés à un contrôle glycémique insatisfaisant.


      Plus de la moitié des participants avaient un contrôle glycémique insatisfaisant, révélant la nécessité d'un changement dans l'approche et les stratégies utilisées pour les patients atteints de diabète en Jordanie. Les facteurs associés à un contrôle glycémique qui ont été trouvés dans cette étude devraient être davantage étudiés et utilisés dans la prévention et la gestion du diabète.


      Mots clés

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Canadian Journal of Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Muoio D.M.
        • Newgard C.B.
        Molecular and metabolic mechanisms of insulin resistance and bold beta-cell failure in type 2 diabetes.
        Nat Rev Mol Cell Biol. 2008; 9: 193-205
        • Bonow R.O.
        • Gheorghiade M.
        The diabetes epidemic: A national and global crisis.
        Am J Med. 2004; 116: 2-10
        • Majeed A.
        • El-Sayed A.
        • Khoja T.
        • et al.
        Diabetes in the Middle-East and North Africa: An update.
        Diabetes Res Clin Pract. 2014; 103: 218-222
        • Ajlouni K.
        • Jaddou H.
        • Batieha A.
        Diabetes and impaired glucose tolerance in Jordan: Prevalence and associated risk factors.
        J Intern Med. 1998; 244: 317-323
        • Ajouni K.
        • Khader Y.S.
        • Batieha A.
        • et al.
        An increase in prevalence of diabetes mellitus in Jordan over 10 years.
        J Diabetes Complicat. 2008; 22: 317-324
        • Glasgow R.E.
        • Ruggiero L.
        • Eakin E.G.
        • et al.
        Quality of life and associated characteristics in a large national sample of adults with diabetes.
        Diabetes Care. 1997; 20: 562-567
        • Stumvoll M.
        • Goldstein B.J.
        • von Haeften T.W.
        Type 2 diabetes: Principles of pathogenesis and therapy.
        Lancet. 2005; 365: 1333-1346
        • Stamler J.
        • Vaccaro O.
        • Neaton J.D.
        Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial.
        Diabetes Care. 1993; 16: 434-444
        • Abdallah S.
        • Ahmad A.T.
        • Batieha A.
        Diabetes mellitus: The leading cause of hemodialysis in Jordan.
        East Mediterr Health J. 2007; 13: 803-809
        • Al-Amer R.
        • Sobeh M.M.
        • Zayed A.A.
        Depression among adults with diabetes in Jordan: Risk factors and relationship to blood sugar control.
        J Diabetes Complicat. 2011; 25: 247-252
        • Jbour A.K.
        • Jarrah N.S.
        • Radaideh A.M.
        Prevalence and predictors of diabetic foot syndrome in type 2 diabetes mellitus in Jordan.
        Saudi Med J. 2003; 24: 761-764
        • Koro C.E.
        • Bowlin S.J.
        • Bourgeouis N.
        Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: A preliminary report.
        Diabetes Care. 2004; 27: 17-20
        • American Diabetes Association
        Standards of medical care for patients with diabetes mellitus.
        Diabetes Care. 2003; 26: 33-50
        • Diabetes Control and Complications Trial Research Group
        The absence of a glycemic threshold for the development of long-term complications: The perspective of the diabetes control and complications trial.
        Diabetes. 1996; 45: 1289-1298
        • Turner R.C.
        • Holman R.R.
        • Cull C.A.
        • Prospective U.K.
        Diabetes study (UKPDS) group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).
        Lancet. 1998; 352: 837-853
        • Li T.C.
        • Kardia S.L.
        • Li C.I.
        • et al.
        Glycemic control paradox: Poor glycemic control, associated with higher one-year and eight-year risks of all-cause hospitalization but lower one-year risk of hypoglycemia in patients with type 2 diabetes.
        Metabolism. 2015; 64: 1013-1021
        • Patel A.
        • MacMahon S.
        • Chalmers J.
        • et al.
        Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
        N Engl J Med. 2008; 358: 2560-2572
        • Gall M.A.
        • Borch-Johnsen K.
        • Hougaard P.
        • et al.
        Albuminuria and unsatisfactory glycemic control predict mortality in NIDDM.
        Diabetes. 1995; 44: 1303-1309
        • Turner R.C.
        • Millns H.
        • Neil H.A.
        • et al.
        Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23).
        BMJ. 1998; 316: 823-828
        • Engum A.
        • Mykletun A.
        • Midthjell K.
        • et al.
        Depression and diabetes: A large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and 2 diabetes.
        Diabetes Care. 2005; 28: 1904-1909
        • Nichols G.A.
        • Hillier T.A.
        • Javor K.J.
        • et al.
        Predictors of glycemic control in insulin-using adults with type 2 diabetes.
        Diabetes Care. 2000; 23: 273-277
        • Khattab M.
        • Khader Y.S.
        • Al-Khawaldeh A.
        • et al.
        Factors associated with unsatisfactory glycemic control among patients with type 2 diabetes.
        J Diabetes Complicat. 2010; 24: 84-89
        • Adham M.
        • Froelicher E.S.
        • Batieha A.
        • et al.
        Glycaemic control and its associated factors in type 2 diabetic patients in Amman, Jordan.
        East Mediterr Health J. 2010; 16: 732-739
        • Valle T.
        • Koivisto V.A.
        • Reunanen A.
        • et al.
        Glycemic control in patients with diabetes in Finland.
        Diabetes Care. 1999; 22: 575-579
        • Akbar D.H.
        Low rates of diabetic patients reaching satisfactory control target.
        East Mediterr Health J. 2001; 7: 671-678
        • Saaddine J.B.
        • Cadwell B.
        • Gregg E.W.
        • et al.
        Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002.
        Ann Intern Med. 2006; 144: 465-474
        • Rothenbacher D.
        • Ruter G.
        • Saam S.
        • et al.
        Younger patients with type 2 diabetes need better glycemic control: Results of a community-based study describing factors associated with a high HbA1c value.
        Br J Gen Pract. 2003; 53: 389-391
        • Baskar V.
        • Kamalakannan D.
        • Holland M.R.
        • et al.
        The prevalence of hypertension and utilization of antihypertensive therapy in a district diabetes population.
        Diabetes Care. 2002; 25: 2107-2108
        • Tseng C.H.
        Higher risk of hypertension in indigenous type 2 diabetes patients in Taiwan.
        J Hypertens. 2006; 24: 1817-1821
        • Tesfaye S.
        • Chaturvedi N.
        • Eaton S.E.
        • et al.
        Vascular risk factors and diabetic neuropathy.
        N Engl J Med. 2005; 352: 341-350
        • Schutta M.H.
        Diabetes and hypertension: Epidemiology of the relationship and pathophysiology of factors associated with these comorbid conditions.
        J Cardiometab Syndr. 2007; 2: 124-130
        • Mubarak F.M.
        • Forelicher E.S.
        • Jaddou H.Y.
        • et al.
        Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan.
        Ann Saudi Med. 2008; 28: 346-351
        • Juarez D.T.
        • Santell T.
        • Tokumaru S.
        Factors associated with poor glycemic control or wide glycemic variability among diabetic patients in Hawaii 2006–2009.
        Prev Chronic Dis. 2012; 9: 120065
        • Darawad M.W.
        • Mosleh S.
        • Khalil A.
        Investigating physical exercise among Jordanians with diabetes mellitus.
        Health. 2016; 8: 181-189
        • Abuyassin B.
        • Laher I.
        Obesity-linked diabetes in the Arab world: A review.
        East Mediterr Health J. 2015; 21: 420-439
        • Khader Y.
        • Batieha A.
        • Ajlouni H.
        • et al.
        Obesity in Jordan: Prevalence, associated factors, comorbidities, and change in prevalence over ten years.
        Metab Syndr Relat Disord. 2008; 6: 113-120
        • Ajlouni K.
        • Jaddou H.
        • Batieha A.
        Obesity in Jordan.
        Int J of Obes Relat Metab Disord. 1998; 22: 624-628
        • Zimmet P.
        • Alberti K.G.
        • Shaw J.
        Global and societal implications of the diabetes epidemic.
        Nature. 2001; 414: 782-787
        • Reeder B.A.
        • Senthilselvan A.
        • Despres J.P.
        • et al.
        The association of cardiovascular disease risk factors with central obesity in Canada.
        CMAJ. 1997; 157: 39-45
        • Ashwin K.
        • Shivaprakash G.
        • Prabha A.
        Body mass index and waist circumference in type II diabetes mellitus patients attending a diabetes clinic.
        Int J Biol Med Res. 2011; 12: 636-638
        • Bae J.P.
        • Lage M.J.
        • Mo D.
        • et al.
        Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009–2011.
        J Diabetes Complicat. 2016; 30: 212-220
        • Rock C.L.
        • Flatt S.W.
        • Pakiz B.
        • et al.
        Weight loss, glycemic control, and cardiovascular disease risk factors in response to differential diet composition in a weight loss program in type 2 diabetes mellitus: A randomized controlled trial.
        Diabetes Care. 2014; 37: 1578-1580
        • Spann S.J.
        • Nutting P.A.
        • Galliher J.M.
        • et al.
        Management of type 2 diabetes in the primary care setting: A practice-based research network study.
        Ann Fam Med. 2006; 4: 23-31
        • Haffner S.
        Diabetes, hyperlipidemia, and coronary artery disease.
        Am J Cardiol. 1999; 83: 17-21
        • Khader Y.S.
        • Batieha A.
        • El-Khateeb M.
        • et al.
        Prevalence of dyslipidemia and its associated factors among Jordanian adults.
        J Clin Lipidol. 2010; 4: 53-58
        • Habib S.S.
        • Aslan M.
        Risk factors, knowledge and health status in diabetic patients.
        Saudi Med J. 2003; 24: 1219-1224
        • Nikkila E.A.
        • Taskinen M.R.
        Lipoprotein lipase of adipose tissue and skeletal muscle in human obesity: Response to glucose and to semistarvation.
        Metabolism. 1981; 30: 810-817
        • Hassan M.A.
        • Al Akour N.
        • Aburas M.M.
        Relationship between motivational styles and glycemic control in Jordanian patients with type II diabetes mellitus.
        J Diabetes. 2016; (In Press)
        • Khader Y.S.
        • Batieha A.
        • Jaddou H.
        • et al.
        Anthropometric cutoff values for detecting metabolic abnormalities in Jordanian adults.
        Diabetes Metab Syndr Obes. 2010; 3: 395-402
        • Obeidat A.A.
        • Ahmad M.N.
        • Haddad F.H.
        • et al.
        Evaluation of several anthropometric indices of obesity as predictors of metabolic syndrome in Jordanian adults.
        Nutr Hosp. 2015; 32: 667-677